The WACC of Indofarma Tbk PT (INAF.JK) is 8.4%.
| Range | Selected | |
| Cost of equity | 14.10% - 17.10% | 15.60% |
| Tax rate | 22.00% - 23.20% | 22.60% |
| Cost of debt | 4.00% - 7.30% | 5.65% |
| WACC | 7.1% - 9.7% | 8.4% |
| Category | Low | High |
| Long-term bond rate | 6.6% | 7.1% |
| Equity market risk premium | 7.9% | 8.9% |
| Adjusted beta | 0.95 | 1.07 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 14.10% | 17.10% |
| Tax rate | 22.00% | 23.20% |
| Debt/Equity ratio | 1.8 | 1.8 |
| Cost of debt | 4.00% | 7.30% |
| After-tax WACC | 7.1% | 9.7% |
| Selected WACC | 8.4% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for INAF.JK:
cost_of_equity (15.60%) = risk_free_rate (6.85%) + equity_risk_premium (8.40%) * adjusted_beta (0.95) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.